ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2016; 5(3): 82-87


SYNTHESIS AND CYTOTOXIC ACTIVITY OF NOVEL TETRAHYDROBENZO[b]THIOPHENE-DERIVED HETEROCYCLES

Wagnat W. Wardakhan, Faten I. Hamed, Eman M. Samir.



Abstract
Download PDF Post

Series of thiophene, thiazole, and pyrimidine derivatives based on the ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
starting material were synthesized, and cytotoxic activity of synthesized compounds was evaluated. Results showed that three compounds,
viz. (2)-2-(4-methyl-3-phenylthiazole-2(3H)-ylidenea-mino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile, ethyl 2-(6-amino-4-imino3-phenyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate, and 4-imino-3-phenyl-3,4,5,6,7,8-
hexahydrobenzo[4,5]-thieno[2,3-d]pyrimidine-2-thiol, were the most active towards MCF-7 (breast adenocarcinoma), NCI-H460 (nonsmall cell lung cancer), and SF-268 (CNS cancer), but they were not active towards normal fibroblasts human cell line (WI-38). The
toxicity of selected compounds against shrimp larvae was also studied.

Key words: Tetrahydrobenzo[b]thiophene, thiazole, pyrimidine, thieno[d]pyrimidine, cytotoxic activity





Bibliomed Article Statistics

33
34
30
37
37
33
20
22
43
37
29
17
R
E
A
D
S

16

115

135

33

68

25

12

15

18

16

22

19
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.